Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

TRISHA WISE-DRAPER

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1306162367
CMS profile
1348174
Location
CINCINNATI, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$14,141.99

15 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Merck Sharp & Dohme LLC $8,235.00 2
Genmab U.S., Inc. $5,764.51 10
EMD Serono, Inc. $142.48 3

Page 1 of 1; records 1–15 of 15 matching records. This page contains 15 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

TRISHA WISE-DRAPER

NPI 1306162367 · CMS profile ID 1348174

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

CINCINNATI, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–15 of 15 matching records. This page contains 15 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1306162367?year=2024&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
TRISHA WISE-DRAPER, NPI 1306162367, CMS profile ID 1348174. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–15 of 15 matching records. This page contains 15 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1306162367?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). TRISHA WISE-DRAPER, NPI 1306162367, CMS profile ID 1348174. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–15 of 15 matching records. This page contains 15 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1306162367?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
TRISHA WISE-DRAPER, NPI 1306162367, CMS profile ID 1348174, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–15 of 15 matching records. This page contains 15 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1306162367?year=2024&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

15 matching records · $14,141.99 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 15 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–15 of 15.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Merck Sharp & Dohme LLC $6,100.0009/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141633371 CMS
Genmab U.S., Inc. $4,585.0008/30/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1126833123 CMS
Genmab U.S., Inc. $44.0008/18/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1126833109 CMS
Genmab U.S., Inc. $65.0708/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1126833111 CMS
Genmab U.S., Inc. $50.7908/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1126833117 CMS
Genmab U.S., Inc. $26.7708/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1126833119 CMS
Genmab U.S., Inc. $194.2608/16/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1126833113 CMS
Genmab U.S., Inc. $120.0608/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1126833115 CMS
Genmab U.S., Inc. $240.0008/16/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1126833121 CMS
Genmab U.S., Inc. $119.6008/16/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1126833125 CMS
Merck Sharp & Dohme LLC $2,135.0007/29/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141633369 CMS
Genmab U.S., Inc. $318.9607/19/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1126833127 CMS
EMD Serono, Inc. $71.7801/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1120246121 CMS
EMD Serono, Inc. $45.6101/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1120246133 CMS
EMD Serono, Inc. $25.0901/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1120246147 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $262.13 3
PY2020 $590.34 6
PY2021 $1,500.00 1
PY2023 $7,777.55 11
PY2024 $14,141.99 15
PY2025 $19,550.73 20

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $1,091,344.57 191
PY2024 Recipient $1,142.00 1
PY2024 Principal investigator $1,113,643.03 103
PY2023 Principal investigator $647,553.50 123
PY2022 Principal investigator $951,903.86 101
PY2021 Principal investigator $1,602,672.00 113
PY2020 Recipient $2,270.00 3
PY2020 Principal investigator $2,351,551.68 45
PY2019 Principal investigator $1,957,016.08 55

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

191 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $27,422.50 12/25/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI
Phase II study to evaluate amivantamab in recurrent and metastatic adenoid cystic carcinoma No dispute reported 06/30/2026 1175348969
Principal investigator 1 Ares Trading SA $658.80 12/22/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196599
Principal investigator 1 Daiichi Sankyo Company LTD $9,342.00 12/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1186252563
Principal investigator 1 Daiichi Sankyo Inc. $874.00 12/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386377
Principal investigator 1 Daiichi Sankyo Inc. $3,800.00 12/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386395
Principal investigator 1 Daiichi Sankyo Inc. $874.00 12/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386411
Principal investigator 1 Daiichi Sankyo Inc. $3,794.00 12/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386443
Principal investigator 1 Ares Trading SA $3,030.00 11/21/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196577
Principal investigator 1 Ares Trading SA $4,050.00 11/21/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196593
Principal investigator 1 Ares Trading SA $270.00 11/21/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196597
Principal investigator 1 Ares Trading SA $250.00 11/21/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196601
Principal investigator 1 Daiichi Sankyo Company LTD $82,644.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1186252561
Principal investigator 1 Daiichi Sankyo Inc. $1,878.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386369
Principal investigator 1 Daiichi Sankyo Inc. $874.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386371
Principal investigator 1 Daiichi Sankyo Inc. $1,962.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386373
Principal investigator 1 Daiichi Sankyo Inc. $4,677.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386375
Principal investigator 1 Daiichi Sankyo Inc. $1,304.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386379
Principal investigator 1 Daiichi Sankyo Inc. $874.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386381
Principal investigator 1 Daiichi Sankyo Inc. $3,966.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386383
Principal investigator 1 Daiichi Sankyo Inc. $1,962.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386385
Principal investigator 1 Daiichi Sankyo Inc. $3,800.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386387
Principal investigator 1 Daiichi Sankyo Inc. $874.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386389
Principal investigator 1 Daiichi Sankyo Inc. $3,800.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386391
Principal investigator 1 Daiichi Sankyo Inc. $3,800.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386393
Principal investigator 1 Daiichi Sankyo Inc. $1,962.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386397
Principal investigator 1 Daiichi Sankyo Inc. $2,958.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386399
Principal investigator 1 Daiichi Sankyo Inc. $2,064.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386401
Principal investigator 1 Daiichi Sankyo Inc. $2,064.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386403
Principal investigator 1 Daiichi Sankyo Inc. $1,406.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386405
Principal investigator 1 Daiichi Sankyo Inc. $4,267.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386407
Principal investigator 1 Daiichi Sankyo Inc. $4,267.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386409
Principal investigator 1 Daiichi Sankyo Inc. $874.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386413
Principal investigator 1 Daiichi Sankyo Inc. $4,278.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386415
Principal investigator 1 Daiichi Sankyo Inc. $3,655.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386417
Principal investigator 1 Daiichi Sankyo Inc. $1,686.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386419
Principal investigator 1 Daiichi Sankyo Inc. $874.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386421
Principal investigator 1 Daiichi Sankyo Inc. $1,962.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386423
Principal investigator 1 Daiichi Sankyo Inc. $874.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386425
Principal investigator 1 Daiichi Sankyo Inc. $874.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386427
Principal investigator 1 Daiichi Sankyo Inc. $3,794.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386429
Principal investigator 1 Daiichi Sankyo Inc. $1,405.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386431
Principal investigator 1 Daiichi Sankyo Inc. $4,267.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386433
Principal investigator 1 Daiichi Sankyo Inc. $874.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386435
Principal investigator 1 Daiichi Sankyo Inc. $3,794.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386437
Principal investigator 1 Daiichi Sankyo Inc. $3,800.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386439
Principal investigator 1 Daiichi Sankyo Inc. $874.00 11/17/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386441
Principal investigator 1 AstraZeneca Pharmaceuticals LP $173,950.00 11/01/2025 Non-covered Recipient Entity
UC HEALTHCARE SYSTEM
An Open-label, Phase II Study of Durvalumab (MEDI4736) in combination with Cetuximab in Previously Treated Metastatic Head and Neck Squamous Cell Carcinoma No dispute reported 06/30/2026 1185553053
Principal investigator 1 Iovance Biotherapeutics, Inc. $2,357.90 10/27/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252498855
Principal investigator 1 Iovance Biotherapeutics, Inc. $4,596.80 10/27/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252498857
Principal investigator 1 Iovance Biotherapeutics, Inc. $3,904.05 10/27/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252498859
Principal investigator 1 Iovance Biotherapeutics, Inc. $2,674.95 10/27/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252498861
Principal investigator 1 Iovance Biotherapeutics, Inc. $3,754.45 10/27/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252498863
Principal investigator 1 Iovance Biotherapeutics, Inc. $1,147.50 10/27/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252498865
Principal investigator 1 Iovance Biotherapeutics, Inc. $2,357.90 10/27/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252498867
Principal investigator 1 Iovance Biotherapeutics, Inc. $3,904.05 10/27/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252498879
Principal investigator 1 Iovance Biotherapeutics, Inc. $2,383.40 10/27/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252498881
Principal investigator 1 Iovance Biotherapeutics, Inc. $1,609.05 10/27/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252498883
Principal investigator 1 Iovance Biotherapeutics, Inc. $3,277.60 10/27/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252498885
Principal investigator 1 Iovance Biotherapeutics, Inc. $2,842.40 10/27/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252498887
Principal investigator 1 Iovance Biotherapeutics, Inc. $2,584.00 10/27/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252498889
Principal investigator 1 Iovance Biotherapeutics, Inc. $2,842.40 10/27/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252498891
Principal investigator 1 Iovance Biotherapeutics, Inc. $1,924.40 10/27/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252498893
Principal investigator 1 Iovance Biotherapeutics, Inc. $2,187.90 10/27/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252498895
Principal investigator 1 Ares Trading SA $1,008.00 10/24/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196565
Principal investigator 1 Ares Trading SA $1,008.00 10/24/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196567
Principal investigator 1 Ares Trading SA $1,008.00 10/24/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196569
Principal investigator 1 Ares Trading SA $1,008.00 10/24/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196571
Principal investigator 1 Ares Trading SA $1,008.00 10/24/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196573
Principal investigator 1 Ares Trading SA $1,008.00 10/24/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196575
Principal investigator 1 Ares Trading SA $948.00 10/24/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196579
Principal investigator 1 Ares Trading SA $948.00 10/24/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196581
Principal investigator 1 Ares Trading SA $948.00 10/24/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196583
Principal investigator 1 Ares Trading SA $948.00 10/24/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196585
Principal investigator 1 Ares Trading SA $948.00 10/24/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196587
Principal investigator 1 Ares Trading SA $948.00 10/24/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196589
Principal investigator 1 Ares Trading SA $948.00 10/24/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196591
Principal investigator 1 Ares Trading SA $438.00 10/24/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196595
Principal investigator 1 Iovance Biotherapeutics, Inc. $270.00 09/10/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252497631
Principal investigator 1 Iovance Biotherapeutics, Inc. $1,667.25 09/10/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252497637
Principal investigator 1 Iovance Biotherapeutics, Inc. $2,477.25 09/10/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252497641
Principal investigator 1 Iovance Biotherapeutics, Inc. $561.60 09/10/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252497649
Principal investigator 1 Iovance Biotherapeutics, Inc. $330.75 09/10/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252497651
Principal investigator 1 Iovance Biotherapeutics, Inc. $1,012.50 09/10/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252497653
Principal investigator 1 Iovance Biotherapeutics, Inc. $2,004.75 09/10/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252497657
Principal investigator 1 Iovance Biotherapeutics, Inc. $86.40 09/10/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252497659
Principal investigator 1 Iovance Biotherapeutics, Inc. $3,754.62 07/31/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252497999
Principal investigator 1 Iovance Biotherapeutics, Inc. $1,147.50 07/31/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252498001
Principal investigator 1 Janssen Research & Development, LLC $22,263.19 07/29/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI
Phase II study to evaluate amivantamab in recurrent and metastatic adenoid cystic carcinoma No dispute reported 06/30/2026 1175348860
Principal investigator 1 Iovance Biotherapeutics, Inc. $7,290.00 07/25/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252497621
Principal investigator 1 Iovance Biotherapeutics, Inc. $6,750.00 07/25/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252497623
Principal investigator 1 Iovance Biotherapeutics, Inc. $1,216.00 07/25/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252497625
Principal investigator 1 Iovance Biotherapeutics, Inc. $18,900.00 07/25/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252497627
Principal investigator 1 Iovance Biotherapeutics, Inc. $270.00 07/25/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252497629
Principal investigator 1 Iovance Biotherapeutics, Inc. $3,334.50 07/25/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252497633
Principal investigator 1 Iovance Biotherapeutics, Inc. $1,667.25 07/25/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252497635
Principal investigator 1 Iovance Biotherapeutics, Inc. $2,477.25 07/25/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252497639
Principal investigator 1 Iovance Biotherapeutics, Inc. $13,500.00 07/25/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252497643
Principal investigator 1 Iovance Biotherapeutics, Inc. $2,025.00 07/25/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252497645
Principal investigator 1 Iovance Biotherapeutics, Inc. $280.80 07/25/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252497647
Principal investigator 1 Iovance Biotherapeutics, Inc. $2,004.75 07/25/2025 Non-covered Recipient Entity
University of Cincinnati Cancer Center
NCT05361174 No dispute reported 06/30/2026 1252497655
Principal investigator 1 Janssen Research & Development, LLC $11,045.00 07/21/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI
Phase II study to evaluate amivantamab in recurrent and metastatic adenoid cystic carcinoma No dispute reported 06/30/2026 1175348869
Principal investigator 1 Ares Trading SA $562.80 07/01/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196557
Principal investigator 1 Ares Trading SA $948.00 07/01/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196559
Principal investigator 1 Ares Trading SA $948.00 07/01/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196561
Principal investigator 1 Ares Trading SA $1,008.00 07/01/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196563
Principal investigator 1 Coherus Oncology, Inc. $7,000.00 06/30/2025 Non-covered Recipient Entity
University of Cincinnati
RTOG1 No dispute reported 06/30/2026 1235253246
Principal investigator 1 Coherus Oncology, Inc. $3,000.00 06/30/2025 Non-covered Recipient Entity
University of Cincinnati
RTOG1 No dispute reported 06/30/2026 1235253250
Principal investigator 1 Coherus Oncology, Inc. $2,000.00 06/30/2025 Non-covered Recipient Entity
University of Cincinnati
RTOG1 No dispute reported 06/30/2026 1235253254
Principal investigator 1 Janssen Research & Development, LLC $4,452.50 06/25/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI
Phase II study to evaluate amivantamab in recurrent and metastatic adenoid cystic carcinoma No dispute reported 06/30/2026 1175349008
Principal investigator 1 GlaxoSmithKline, LLC. $80,706.66 06/03/2025 Non-covered Recipient Entity
UC HEALTH PHARMACY
AN OPEN-LABEL, PHASE II STUDY EVALUATING THE EFFICACY OF NIRAPARIB AND No dispute reported 06/30/2026 1192188627
Principal investigator 1 Ares Trading SA $1,008.00 05/26/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196553
Principal investigator 1 Ares Trading SA $752.40 05/26/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196555
Principal investigator 1 Daiichi Sankyo Company LTD $17,965.00 05/05/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1186252553
Principal investigator 1 Daiichi Sankyo Inc. $1,686.00 05/05/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386353
Principal investigator 1 Daiichi Sankyo Inc. $3,872.00 05/05/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386355
Principal investigator 1 Daiichi Sankyo Inc. $1,837.00 05/05/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386357
Principal investigator 1 Daiichi Sankyo Inc. $1,962.00 05/05/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386359
Principal investigator 1 Daiichi Sankyo Inc. $1,406.00 05/05/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386361
Principal investigator 1 Daiichi Sankyo Inc. $1,266.00 05/05/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386363
Principal investigator 1 Daiichi Sankyo Inc. $2,064.00 05/05/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386365
Principal investigator 1 Daiichi Sankyo Inc. $3,872.00 05/05/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386367
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $120,626.69 03/26/2025 Non-covered Recipient Entity
University Of Cincinnati
A Phase 1/2 First-in-Human Study of BMS-986249 Alone and in Combination with Nivolumab in Advanced Solid Tumors No dispute reported 06/30/2026 1235992649
Principal investigator 1 Ares Trading SA $948.00 03/24/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196527
Principal investigator 1 Ares Trading SA $948.00 03/24/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196529
Principal investigator 1 Ares Trading SA $948.00 03/24/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196531
Principal investigator 1 Ares Trading SA $948.00 03/24/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196533
Principal investigator 1 Ares Trading SA $1,008.00 03/24/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196541
Principal investigator 1 Ares Trading SA $1,008.00 03/24/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196543
Principal investigator 1 Ares Trading SA $272.40 03/24/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196549
Principal investigator 1 Daiichi Sankyo Company LTD $66,920.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1186252555
Principal investigator 1 Daiichi Sankyo Inc. $2,064.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386445
Principal investigator 1 Daiichi Sankyo Inc. $1,962.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386447
Principal investigator 1 Daiichi Sankyo Inc. $2,064.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386449
Principal investigator 1 Daiichi Sankyo Inc. $4,677.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386451
Principal investigator 1 Daiichi Sankyo Inc. $1,878.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386453
Principal investigator 1 Daiichi Sankyo Inc. $4,267.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386455
Principal investigator 1 Daiichi Sankyo Inc. $1,962.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386457
Principal investigator 1 Daiichi Sankyo Inc. $1,837.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386459
Principal investigator 1 Daiichi Sankyo Inc. $2,064.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386461
Principal investigator 1 Daiichi Sankyo Inc. $1,962.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386463
Principal investigator 1 Daiichi Sankyo Inc. $1,837.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386465
Principal investigator 1 Daiichi Sankyo Inc. $1,686.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386467
Principal investigator 1 Daiichi Sankyo Inc. $3,966.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386469
Principal investigator 1 Daiichi Sankyo Inc. $1,266.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386471
Principal investigator 1 Daiichi Sankyo Inc. $1,304.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386473
Principal investigator 1 Daiichi Sankyo Inc. $1,406.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386475
Principal investigator 1 Daiichi Sankyo Inc. $3,966.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386478
Principal investigator 1 Daiichi Sankyo Inc. $1,266.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386480
Principal investigator 1 Daiichi Sankyo Inc. $1,266.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386482
Principal investigator 1 Daiichi Sankyo Inc. $3,872.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386484
Principal investigator 1 Daiichi Sankyo Inc. $2,958.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386486
Principal investigator 1 Daiichi Sankyo Inc. $3,872.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386488
Principal investigator 1 Daiichi Sankyo Inc. $2,064.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386490
Principal investigator 1 Daiichi Sankyo Inc. $3,966.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386532
Principal investigator 1 Daiichi Sankyo Inc. $1,686.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386534
Principal investigator 1 Daiichi Sankyo Inc. $1,962.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386536
Principal investigator 1 Daiichi Sankyo Inc. $1,962.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386540
Principal investigator 1 Daiichi Sankyo Inc. $1,878.00 03/11/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386544
Principal investigator 1 Genentech, Inc. $3,515.91 02/18/2025 Non-covered Recipient Entity
UC HEALTH LLC
PH III open label study atezo vs BSC following adjuvant chemo in stage IB IIIA NSCLC No dispute reported 06/30/2026 1211674893
Principal investigator 1 Daiichi Sankyo Company LTD $52,098.00 02/12/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1186252559
Principal investigator 1 Daiichi Sankyo Inc. $1,962.00 02/12/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386496
Principal investigator 1 Daiichi Sankyo Inc. $1,962.00 02/12/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386498
Principal investigator 1 Daiichi Sankyo Inc. $1,686.00 02/12/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386500
Principal investigator 1 Daiichi Sankyo Inc. $2,064.00 02/12/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386502
Principal investigator 1 Daiichi Sankyo Inc. $2,064.00 02/12/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386504
Principal investigator 1 Daiichi Sankyo Inc. $1,837.00 02/12/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386506
Principal investigator 1 Daiichi Sankyo Inc. $1,406.00 02/12/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386508
Principal investigator 1 Daiichi Sankyo Inc. $3,872.00 02/12/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386510
Principal investigator 1 Daiichi Sankyo Inc. $874.00 02/12/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386512
Principal investigator 1 Daiichi Sankyo Inc. $874.00 02/12/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386514
Principal investigator 1 Daiichi Sankyo Inc. $874.00 02/12/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386516
Principal investigator 1 Daiichi Sankyo Inc. $4,278.00 02/12/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386518
Principal investigator 1 Daiichi Sankyo Inc. $3,800.00 02/12/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386520
Principal investigator 1 Daiichi Sankyo Inc. $4,267.00 02/12/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386522
Principal investigator 1 Daiichi Sankyo Inc. $3,655.00 02/12/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386524
Principal investigator 1 Daiichi Sankyo Inc. $3,655.00 02/12/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386526
Principal investigator 1 Daiichi Sankyo Inc. $2,958.00 02/12/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386528
Principal investigator 1 Daiichi Sankyo Inc. $4,778.00 02/12/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386530
Principal investigator 1 Daiichi Sankyo Inc. $3,966.00 02/12/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386538
Principal investigator 1 Daiichi Sankyo Inc. $1,266.00 02/12/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386542
Principal investigator 1 Ares Trading SA $616.80 01/22/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196525
Principal investigator 1 Ares Trading SA $1,008.00 01/22/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196535
Principal investigator 1 Ares Trading SA $3,030.00 01/22/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196537
Principal investigator 1 Ares Trading SA $270.00 01/22/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196539
Principal investigator 1 Ares Trading SA $948.00 01/22/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196545
Principal investigator 1 Ares Trading SA $948.00 01/22/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196547
Principal investigator 1 Ares Trading SA $4,050.00 01/22/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
An Open-Label, Multicenter Follow-up Study to Collect Long-Term Data on Participant from Multiple Avelumab (MSB0010718C) Clinical Studies No dispute reported 06/30/2026 1241196551
Principal investigator 1 Eli Lilly and Company $10,278.00 01/21/2025 Non-covered Recipient Entity
UNIVERSITY OF CINCINNATI PHYSICIANS
A MULTICENTER, RANDOMIZED, OPEN LABEL, PHASE 3 TRIAL COMPARING SELPERCATINIB TO PHYSICIANS CHOICE OF CABOZANTINIB OR VANDETANIB IN PATIENTS WITH PROGRESSIVE, ADVANCED, KINASE INHIBITOR NAIVE, RET MUTANT MEDULLARY THYROID CANCER (LIBRETTO 531) No dispute reported 06/30/2026 1187893732
Principal investigator 1 Daiichi Sankyo Company LTD $3,105.00 01/07/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1186252557
Principal investigator 1 Daiichi Sankyo Inc. $405.00 01/07/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386492
Principal investigator 1 Daiichi Sankyo Inc. $2,700.00 01/07/2025 Non-covered Recipient Entity
University Of Cincinnati
DS1055-A-J101 No dispute reported 06/30/2026 1223386494